The Clorox Company $CLX Shares Sold by Northeast Investment Management

Northeast Investment Management reduced its stake in shares of The Clorox Company (NYSE:CLX) by 20.0% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 34,489 shares of the company’s stock after selling 8,597 shares during the period. Northeast Investment Management’s holdings in Clorox were worth $4,252,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. Center for Financial Planning Inc. purchased a new stake in shares of Clorox in the third quarter worth about $25,000. Total Investment Management Inc. acquired a new position in Clorox in the second quarter valued at approximately $25,000. True Wealth Design LLC boosted its position in Clorox by 1,020.0% in the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock worth $28,000 after purchasing an additional 204 shares in the last quarter. NewSquare Capital LLC grew its stake in shares of Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after purchasing an additional 193 shares during the period. Finally, Root Financial Partners LLC purchased a new position in shares of Clorox during the 3rd quarter valued at approximately $29,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 2.3%

CLX opened at $123.00 on Wednesday. The company has a market cap of $14.87 billion, a PE ratio of 20.10, a price-to-earnings-growth ratio of 0.62 and a beta of 0.59. The Clorox Company has a twelve month low of $96.66 and a twelve month high of $159.04. The company has a 50-day moving average price of $108.56 and a 200 day moving average price of $113.55. The company has a quick ratio of 0.48, a current ratio of 0.74 and a debt-to-equity ratio of 71.03.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the firm posted $1.55 earnings per share. Clorox’s quarterly revenue was down .8% on a year-over-year basis. Sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. Evercore lowered their price target on shares of Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a report on Wednesday, February 4th. UBS Group increased their target price on shares of Clorox from $115.00 to $121.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 4th. Wall Street Zen upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Jefferies Financial Group reduced their price target on Clorox from $152.00 to $151.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Finally, Morgan Stanley raised their price objective on Clorox from $125.00 to $136.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $118.73.

Insider Activity at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of the firm’s stock in a transaction on Friday, November 21st. The shares were bought at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the acquisition, the director owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. This trade represents a 44.44% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 0.63% of the company’s stock.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.